NCT01568762View on ClinicalTrials.gov

To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

July 31, 2011

Conditions
Asthma
Interventions
DRUG

VAK694

Intravenous infusion

DRUG

VAK694 placebo

Intravenous infusion

DRUG

QAX576

Intravenous infusion

DRUG

QAX576 placebo

Intravenous infusion

Trial Locations (1)

27607

Novartis Investigative Site, Raleigh

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY